FDA rolls out new draft guid­ance on ad­vanced man­u­fac­tur­ing tech

The FDA un­veiled on Tues­day a draft guid­ance for phar­ma­ceu­ti­cal com­pa­nies who want to use “ad­vanced man­u­fac­tur­ing tech­nol­o­gy” (ATM) in drug de­vel­op­ment in or­der to short­en and im­prove sup­ply chains in the US.

ATM can be de­fined as a “nov­el” tech­nol­o­gy not al­ready used dur­ing phar­ma­ceu­ti­cal drug man­u­fac­tur­ing for small mol­e­cule drugs or bi­o­log­ics that aims to make process­es more ef­fi­cient. The agency en­cour­ages the use of tech­nol­o­gy to im­prove the man­u­fac­tur­ing process of med­i­cines, stat­ing it can im­prove the qual­i­ty, re­li­a­bil­i­ty and ro­bust­ness of sup­ply, as well as re­duce drug de­vel­op­ment time.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER